Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

PloS one

International journal of biological macromolecules

Journal of medical Internet research

international journal of psychology : journal international de psychologie

scientific data

neurobiology of aging

human mutation

neurologia (barcelona, spain)

ethnicity & health

JMIR formative research

clinical pharmacology and therapeutics

revista de enfermeria (barcelona, spain)

zhonghua nei ke za zhi

journal of neuropathology and experimental neurology

annals of clinical and translational neurology

the annals of pharmacotherapy

foodborne pathogens and disease

metabolic brain disease

journal of medical primatology

[1] Using Computer Tablets to Improve Moods for Older Adults With Dementia and Interactions With Their Caregivers: Pilot Intervention Study.

[2] Fostering trust and sharing responsibility to increase access to dementia care for immigrant older adults.

[3] Circadian learning and memory changes in Aβ1-42 induced Alzheimer's mice.

[4] Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.

[5] Dietary pattern in relation to the risk of Alzheimer's disease: a systematic review.

[6] A new purified Lawsoniaside remodels amyloid-β fibrillation into a less toxic and non-amyloidogenic pathway.

[7] Global nutrition 1990-2015: A shrinking hungry, and expanding fat world.

[8] BLOND, a building-level office environment dataset of typical electrical appliances.

[9] Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.

[10] Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects.

[11] [Responsibility versus informed consent nurse].

[12] Analysis of the bone metabolism by quantitative computer tomography and clinical chemistry in a primate model (Callithrix jacchus).

[13] SALMATcor: microagglutination for Salmonella flagella serotyping.

[14] Effects of country size and language similarity on international attitudes: a six-nation study.

[15] A Web-Based Psychoeducational Program for Informal Caregivers of Patients With Alzheimer’s Disease: A Pilot Randomized Controlled Trial

[16] implication of integrative treatment strategies for real-life geriatric patients with multiple, chronic illnesses: a 60-month follow-up of a naturalistic study

[17] qualidade de vida de idosos com doença de alzheimer e de seus cuidadores calidad de vida de los ancianos con enfermedad de alzheimer y sus cuidadores quality of life of elders with alzheimer's disease and of their caregivers

[18] three-class differential diagnosis among alzheimer disease, frontotemporal dementia and controls

[19] prion protein and aging

[20] successful therapies for alzheimer’s disease: why so many in animal models and none in humans?

[21] endocannabinoid mediates excitatory synaptic function of β-neurexins

[22] reducing the levels of akt activation by pdk1 knock-in mutation protects neuronal cultures against synthetic amyloid-beta peptides

[23] genetics of alzheimer’s disease: lessons learned in two decades

[24] current pathophysiological concepts in cerebral small vessel disease

[25] molecular magnetic resonance imaging of brain-immune interactions

[26] autosomal dominant alzheimer disease: a unique resource to study csf biomarker changes in preclinical ad

[27] the involvement of micrornas in neurodegenerative diseases

[28] aß degradation--the inside story

[29] myeloid extracellular vesicles: messengers from the demented brain

[30] editorial note. golgi pathology in neurodegenerative diseases.

[31] the potential of pathological protein fragmentation in blood-based biomarker development for dementia – with emphasis on alzheimer’s disease

[32] the pivotal role of semantic memory in remembering the past and imagining the future

[33] glia and zinc in ageing and alzheimer’s disease: a mechanism for cognitive decline?

[34] Plasma Neurofilament Light Chain Levels Are Associated With Cortical Hypometabolism in Alzheimer Disease Signature Regions.

[35] Vitamin D concentration and risk of Alzheimer disease: A meta-analysis of prospective cohort studies.

[36] Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review.

[37] Automatic detection of alzheimer disease based on histogram and random forest

[38] Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease

[39] Somatic mutation that affects transcription factor binding upstream of CD55 in the temporal cortex of a late-onset Alzheimer disease patient.

[40] Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation.

[41] An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.

[42] Commercially Available Mobile Apps for Caregivers of People With Alzheimer Disease or Other Related Dementias: Systematic Search.

[43] Comprehension of written texts for the assessment of clinical competence and decision making in people with mild to moderate Alzheimer disease.

[44] Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.

[45] Autosomal dominantly inherited alzheimer disease: Analysis of genetic subgroups by machine learning

[46] Alzheimer disease starts in childhood in polluted Metropolitan Mexico City. A major health crisis in progress.

[47] Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects.

[48] Predicting the rate of cognitive decline in aging and early Alzheimer disease.

[49] Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias.

[50] A Deep Siamese Convolution Neural Network for Multi-Class Classification of Alzheimer Disease.

[51] Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders

[52] Phosphorylated tau in neuritic plaques of APP sw /Tau vlw transgenic mice and Alzheimer disease

[53] Opportunities and challenges in developing Alzheimer disease therapeutics

[54] three-class differential diagnosis among alzheimer disease, frontotemporal dementia and controls

[55] lewy body variant of alzheimer disease

[56] insulin and alzheimer disease: type 3 diabetes?

[57] traditional used plants against cognitive decline and alzheimer disease

[58] detection of membrane fluidity in submitochondrial particles of platelets and erythrocyte membranes from mexican patients with alzheimer disease by intramolecular excimer formation of 1,3 dipyrenylpropane

[59] autosomal dominant alzheimer disease: a unique resource to study csf biomarker changes in preclinical ad

[60] differential processing of natural scenes in typical and atypical alzheimer disease measured with a saccade choice task

[61] mitochondrial molecular abnormalities revealed by proteomic analysis of hippocampal organelles of mice triple transgenic for alzheimer disease

[62] alternative neural circuitry that might be impaired in the development of alzheimer disease

[63] Treatment Challenges and the Hope of Emerging Therapies in Early-Stage Alzheimer Disease

[64] What’s not in the news headlines or titles of Alzheimer disease articles? #InMice

[65] Mindfulness-Based App to Reduce Stress in Caregivers of Persons With Alzheimer Disease and Related Dementias: Protocol for a Single-Blind Feasibility Proof-of-Concept Randomized Controlled Trial.

[66] Brain ¹⁸F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation

[67] Evaluating Alzheimer Disease with Flortaucipir and Florbetapir PET: A Clinical Case Series

[68] Diagnosis of Alzheimer disease: Advances and benefits of florbetapir positron emission tomography (PET) and other amyloid radioligands

[69] Clinical implications and appropriate use of amyloid imaging with florbetapir (¹⁸F) in diagnosis of patients with Alzheimer disease